Neurofeedback to Reduce Spontaneous Recovery of Threat Expectancy
Reducing Spontaneous Recovery Using Functional Connectivity Based Real-time Functional Magnetic Resonance Imaging Neurofeedback Targeting the Memory Control Network
2 other identifiers
interventional
40
1 country
1
Brief Summary
This study tests the efficacy of a new behavioral intervention with the goal of reducing spontaneous recovery of threat expectancy in healthy adults. This real-time functional magnetic resonance imaging (fMRI) neurofeedback intervention delivers feedback based on a functional connection between the prefrontal cortex and the hippocampus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Jul 2025
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 17, 2025
CompletedFirst Submitted
Initial submission to the registry
August 1, 2025
CompletedFirst Posted
Study publicly available on registry
August 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2028
February 23, 2026
February 1, 2026
2.4 years
August 1, 2025
February 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Spontaneous recovery behavior
The investigators will assess neurofeedback related changes in behavioral threat expectancy ratings in a discriminatory Pavlovian conditioning task. Spontaneous recovery is taken as the difference in responding to the conditioned stimulus that was paired with an outcome (CS+) vs. the conditioned stimulus that was not paired with an outcome (CS-) during a test of extinction recall following acquisition and extinction learning.
Baseline and fourth fMRI session (out of four total fMRI sessions). At most 60 days will elapse between the start of data collection for a participant and their final fMRI session.
Secondary Outcomes (1)
Neurofeedback learning
Second and third fMRI sessions (out of four total fMRI sessions). At most 60 days will elapse between the start of data collection for a participant and their final fMRI session.
Study Arms (2)
Active Neurofeedback
EXPERIMENTALActive neurofeedback will reinforce negative dlPFC-hippocampal functional connectivity, as this is expected to increase memory control ability.
Control Neurofeedback
SHAM COMPARATORParticipants in the control neurofeedback group will receive the same instructions as the experimental group, but will receive sham neurofeedback.
Interventions
Active neurofeedback to target a functional connection associated with increased memory control ability
Eligibility Criteria
You may qualify if:
- Adults aged 18-50
- No history of psychiatric disorders or neurological disorders affecting the central nervous system.
- Are not currently taking psychoactive medication or drugs of abuse.
- Must be eligible to enter an MRI (i.e., no permanent metal or medical implants)
- Normal color vision
- Right-handed
- Full reading and writing English comprehension
- Must exhibit spontaneous recovery behavior as determined by an experimenter in a prescreening experimental session
- Must be able to provide informed consent
You may not qualify if:
- Pregnancy (female participants)
- Outside of age range
- History of psychiatric or neurological disease
- Currently taking psychoactive medication or drugs of abuse
- Color blindness
- Primary left-handedness
- Less than full reading and writing English comprehension
- Do not exhibit spontaneous recovery behavior as determined by an experimenter in a prescreening experimental session
- Refusing to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Princeton Neuroscience Institute
Princeton, New Jersey, 08540, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Kenneth A. Norman, Ph.D.
Princeton University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants are always blind to condition assignment. Because of the way that participants are assigned to the active vs. sham neurofeedback conditions, the investigator who is collecting the data will be aware of condition assignment for a small number of participants at the start and end of the study, but otherwise the investigator who is collecting the data will not be aware of condition assignment until after the participant has been run.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 1, 2025
First Posted
August 14, 2025
Study Start
July 17, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
June 1, 2028
Last Updated
February 23, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Anonymized data will be uploaded to the NIMH Data Archive (NDA).